Mindfulness and movement: new program aims to ease fatigue in advanced breast cancer
NCT ID NCT07238023
First seen Jun 25, 2026 · Last updated Sep 11, 2026 · Updated 4 times
Summary
This study tests whether a remotely delivered program that combines mindfulness, physical activity tracking, and social support is acceptable and feasible for people with metastatic breast cancer. The program lasts 8-12 weeks and includes a wearable activity tracker and weekly challenges. Researchers will enroll 38 participants to see if the program is easy to use and enjoyable, and whether it helps improve well-being.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Acceptance- and mindfulness-based physical activity promotion program
- What this could lead to
- If successful, this program could offer a practical, home-based way to help people with metastatic breast cancer stay active and improve their quality of life.
- What could go wrong
- This is a small, early feasibility study with only 38 participants and no control group, so results may not apply broadly. The program requires a smartphone and internet access, which may limit participation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
36 people
The number who actually took part.
- Started
-
Feb 2026
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 99 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion criteria: Having ever received a histologically confirmed diagnosis of stage 4 invasive breast or gynecologic carcinoma (eligible cancer types include epithelial ovarian carcinoma, endometrial/uterine carcinoma, and invasive cervical carcinoma; other rare gynecologic malignancies \[e.g., vaginal, vulvar\] may also be included if approved by the study team) medical clearance from healthcare provider to participate in this study (which encourages unsupervised, low-intensity physical activity such as walking, stretching, and gentle muscle-strengthening exercises) life expectancy of at least 6 months as per the participant's healthcare provider Eastern Cooperative Oncology Group performance status of or 0, 1, or 2 being willing and able to use a smartphone and web interface with or without assistance; if assistance is needed, it must be readily available adequate visual and hearing acuity to use a smartphone and web interface as indicated by self-report adequate motor capacity to use a smartphone and web interface as indicated by self-report willingness to download and use study-specific app(s), the Fitbit mobile application (this requires use of a Google Gmail account), and other mobile applications for study purposes as needed completed baseline survey Exclusion criteria: contraindications to physical activity (e.g., uncontrolled hypertension or cardiac disease noted by the patient's treating healthcare provider) presence of bone metastases deemed unstable and/or high risk by the treating healthcare provider untreated brain metastases history of dementia or other major neurocognitive disorder received a diagnosis of a major psychiatric conditions such as bipolar disorder, psychosis, schizophrenia, or alcoholism that could affect the ability to understand and/or complete the study currently hospitalized enrolled in hospice inability to speak, read, and write in English at the 7th grade level
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Metastatic breast cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
TSET Health Promotion Research Center
Oklahoma City, Oklahoma, 73104, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a blood test reveal when breast cancer treatment stops working?
- New antibody aims to preserve immune checkpoint while fighting cancer
- Can a phone app and mindfulness keep chemo patients moving?
- Zapping a few growing tumors may keep breast cancer drugs working longer
- Can a Two-Drug combo outsmart resistant breast and ovarian cancers?
- Can a platform trial match the right drug combo to each tumor?